This page lists all known medications that could potentially lead to 'Alveolar proteinosis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
Please provide your email address to receive an email when new articles are posted on . In patients with autoimmune pulmonary alveolar proteinosis, daily administration of inhaled molgramostim for 24 ... Healio: Inhaled sargramostim modestly improves arterial oxygen tension in pulmonary alveolar proteinosis Please provide your email address to receive an email when new articles are posted on . Among patients with pulmonary alveolar proteinosis, treatment with daily inhaled recombinant human ...
proteinosis, Yahoo Finance: Savara to Present New Data From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP ... Savara to Present New Data From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP ... News Medical: Study shows pulmonary alveolar proteinosis can be cured by single transfer of monocytes This paves the way towards monocyte-based cellular therapy in diseases associated with macrophage dysfunction, such as the disease known as pulmonary alveolar proteinosis. Using a mouse model for ... Study shows pulmonary alveolar proteinosis can be cured by single transfer of monocytes The novel agent molgramostim improved pulmonary gas exchange in autoimmune pulmonary alveolar proteinosis, a randomized trial showed.
proteinosis, In this rare condition, surfactant builds up in the alveoli as ... Poster Title: Inhaled Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP): Results from the IMPALA-2 Phase 3 Clinical Trial Session: English Poster Discussion “Rare ... Business Wire: Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting Savara Announces Patient Journey Map for People Living with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting
